OpenAI researcher Alisa Liu described the job hunt as "challenging but also super rewarding," and recommended plenty of sleep ...

A tech professional's 12-round interview ordeal at Goldman Sachs concluded with an unexpected logical puzzle, leading him to ...

Imagine walking into a Google interview in the 2000s. It was the place to work, famously tough to get in, and highly ...

President Donald Trump sat for an interview with “Meet the Press” moderator Kristen Welker on Friday, discussing topics including the war with Iran, gas prices and the “anti-weaponization” fund.

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

Recursion is building an industrialized engine for medicine. It operates among biotech stocks, selling access to its proprietary platform and pursuing joint development with major partners like Roche ...

Recursive Superintelligence has raised $650 million at a $4.65 billion valuation in a funding round led by GV and Greycroft, according to the company. The round also included participation from AMD ...

Recursive Superintelligence Inc., a startup that hopes to develop self-improving artificial intelligence models, launched today with $650 million in funding. Alphabet Inc.’s GV fund and Greycroft led ...

Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence. By Cade Metz Reporting from San ...

"TODAY" co-host Savannah Guthrie has opened up about the ongoing search for her mother, detailing the "agony" her family is going through more than seven weeks after her disappearance from her home in ...

JDK 26 moves to general production availability. This short-term release is backed by six months of Premier-level support. Java Development Kit (JDK) 26, the latest standard Java release from Oracle, ...

SALT LAKE CITY, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX) a leading clinical stage TechBio company decoding biology to radically improve lives, today reported business updates and ...